GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Chemical approaches to understanding chondroitin sulfate glycosaminoglycans and their roles in brain plasticity and pathology

$681,131
Linda C Hsieh-Wilson · California Institute Of Technology · R01 · FY2024 · AG

Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis

$681,094
Ellen M. Mowry · Johns Hopkins University · R01 · FY2022 · NR

Mesoscopic Biomarkers of Neurodegeneration and Inflammation with Diffusion MRI

$680,902
Els Fieremans · New York University School Of Medicine · R01 · FY2020 · NS

Functions of IL-17 Family Cytokines and their Signaling Mechanisms in Health and Disease

$680,651
Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Disrupted ciliary signaling in the brain pathology of Tuberous Sclerosis Complex

$680,232
Mustafa None Sahin · Boston Children'S Hospital · R01 · FY2021 · NS

Disrupted Ciliary Signaling in the Brain Pathology of Tuberous Sclerosis Complex

$680,023
Mustafa None Sahin · Boston Children'S Hospital · R01 · FY2022 · NS

High parameter fluorescence activated cell sorter

$679,925
Michael W Deininger · Versiti Blood Health, Inc. · S10 · FY2025 · OD

Neuro-Immune Mechanisms in Brain Plasticity and Aging

$679,890
Mark Mattson · National Institute On Aging · ZIA · FY2017 · AG

High-Resolution, Anisotropic MR Elastography of the Brain

$679,674
Curtis L Johnson · University Of Delaware · R01 · FY2020 · EB

Spinal cord functional connectivity as a biomarker of spinal cord dysfunction

$679,661
Robert L Barry · Massachusetts General Hospital · R01 · FY2021 · EB

Immune Privilege, CNS Autoimmunity, and Clostridium perfringens Epsilon Toxin

$679,650
Timothy Vartanian · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI

Analysis and characterization of a cohort of familial Parkinson's disease exomes

$679,587
John E. Landers · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · NS

HIGHLY EFFICIENT CEREBRAL PERFUSION MRI

$679,356
David Alan Feinberg · Advanced Mri Technology, Llc · R44 · FY2016 · NS

Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models

$679,264
Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2020 · AI

Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models

$679,264
Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2021 · AI

Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models

$679,264
Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2022 · AI

Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models

$679,264
Daniel J. Campbell · Benaroya Research Inst At Virginia Mason · R01 · FY2019 · AI

Heterotrimeric G Protein Signaling In Allergic Inflammation

$678,558
Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Leveraging electronic health records to optimize treatment selection and response in multiple sclerosis

$678,220
Zongqi Xia · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · NS

Cerebrospinal fluid exchange in Alzheimer's disease characterized by advanced MRI techniques

$678,139
Jiadi Xu · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2024 · AG

Prevalence and Prognosis of Pulmonary Hypertension in Adults with Sickle Cell

$677,677
James Taylor · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL

VCP in myopathy and dementia

$677,597
Conrad C Weihl · Washington University · R01 · FY2023 · AG

Novel Diffusion MRI Analyses of White Matter in Schizophrenia

$677,412
Carl-Fredrik Westin · Brigham And Women'S Hospital · R01 · FY2014 · MH

Rheumatic Diseases Research Core Centers

$677,347
Robert A Lafyatis · Boston University Medical Campus · P30 · FY2011 · AR

Regulation Of Immune Responses In Humans and in Experimental Animals

$676,945
Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI